CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
Myoung Kyun Son, Min-Hee Ryu, Joon Oh Park, Seock-Ah Im, Tae-Yong Kim, Su Jin Lee, Baek-Yeol Ryoo, Sook Ryun Park, Yoon-Koo Kang
Cancer Research and Treatment. 2017;49(2):350-357.   Published online 2016 July 19    DOI: https://doi.org/10.4143/crt.2016.067

Excel Download

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
Cancer Research and Treatment. 2017;49(2):350-357   Crossref logo
Link1 Link2 Link3

Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
BioDrugs. 2013;27(5):525-531   Crossref logo
Link1 Link2 Link3

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
Yearbook of Oncology. 2008;2008:303-305   Crossref logo
Link1 Link2

Efficacy and safety of apatinib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib: An open-label, multicenter, single-arm, phase II trial
Annals of Oncology. 2019;30:v698   Crossref logo
Link1 Link2 Link3

Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
Gastric Cancer. 2014;18(3):627-634   Crossref logo
Link1 Link2 Link3

Sunitinib—a new approach following failure of imatinib in patients with advanced gastrointestinal stromal tumor
Nature Clinical Practice Oncology. 2007;4(6):342-343   Crossref logo
Link1 Link2 Link3

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
Gastroenterology Research and Practice. 2014;2014:1-6   Crossref logo
Link1 Link2 Link3

Imatinib/regorafenib/sunitinib
Reactions Weekly. 2020;1826(1):164-164   Crossref logo
Link1 Link2 Link3

Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib
Expert Opinion on Investigational Drugs. 2020;1-10   Crossref logo
Link1

Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
Annals of Oncology. 2018;29:viii583   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.